Dry AMD Monitoring Programs: Building Reliable Recurring Follow-Up

Dry age-related macular degeneration is mostly a waiting game — and that's exactly what makes it operationally dangerous. The clinical task is surveillance: catching the minority of patients who convert to wet AMD inside the narrow window where prompt anti-VEGF treatment preserves vision. A conversion caught at week one is a treatable event; the same conversion discovered at month four is a permanent loss. The difference is rarely clinical skill. It's whether the practice's follow-up machinery actually works.

Stratify, then schedule

Not every dry AMD patient needs the same cadence. Stratify by drusen load, pigmentary changes, fellow-eye history (a wet fellow eye is the single biggest risk multiplier), and genetic or family factors where known. Assign each tier a defined recall interval — and record the tier in a structured field, not free text, so reports can find it. The stratification meeting takes one clinic huddle; the payoff is a schedule that matches risk instead of habit.

Build recall that survives real patients

Passive recall — 'we mailed a card' — loses exactly the elderly population AMD affects most. A working system runs three layers: the appointment booked before the patient leaves (never 'call us in six months'), a reminder sequence at two weeks and three days, and — the layer most practices skip — a missed-appointment recovery list worked weekly by a named owner. Every no-show in an AMD monitoring program is a clinical risk, not a schedule gap. This is the same recall discipline optometry practices run for diabetic exams, applied with higher stakes.

Add the home-monitoring layer

Between visits, symptom vigilance is the early-warning system. At minimum: an Amsler grid taped to the refrigerator, with a 90-second teach-back so the patient can demonstrate what 'new distortion' means and knows to call the same day — not at the next visit. Practices using digital home-monitoring programs add a stronger signal, but the operational rule is identical: every alert routes to a same-week OCT slot held for exactly this purpose. An alert that waits three weeks for an opening defeats the entire program.

Close the loop on every conversion pathway

Map what happens when distortion is reported: who takes the call, what triage script runs, how fast the OCT happens, and how quickly treatment starts if fluid appears — including the prior authorization sprint that follows. Practices that pre-build the auth packet for likely converters cut days off time-to-first-injection.

Who runs the machine

The recall lists, reminder cadence, no-show recovery calls, Amsler re-education touchpoints, and monthly program report are administrative surveillance — steady, scripted, and delegable to a trained eye care virtual assistant at a flat $10/hour, with clinical escalation rules for any symptom report. In ophthalmology, the retina specialist's job is the diagnosis and the injection; the program's job is making sure the right patient is in the chair in time for both to matter.